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Abstract
Background: Non-insulin dependent diabetic patients frequently suffer from fatigue symptoms that result from chronic 
systemic inflammation. Aerobic exercise was proved to modulate systemic inflammation. 
Objective: This study was an attempt to measure the impact of  aerobic exercises on fatigue symptoms related to systemic 
inflammation in obese patients with type 2 diabetes. 
Methods: Eighty obese patients with type 2 diabetes participated in the present study, their age ranged from 40- 58 years 
and their BMI ranged from 31-36 kg/m2  and were assigned to two subgroups; group (A) received aerobic exercise training 
for 12 weeks and  group (B) received no exercise training for 3 months. Measurements of  fatigue symptoms and markers of  
systemic inflammation were assessed before and at the end of  the study for all participants in both groups. 
Results: The mean values of  inflammatory markers (IL-6 and TNF-α) and Multidimensional Fatigue Inventory (MFI) was 
significantly decreased in group (A), while changes were not significant in group (B). Moreover, there were significant differ-
ences between mean levels of  the investigated parameters in group (A) and group (B) at the end of  the study. 
Conclusion: Treadmill walking exercise training is an effective treatment policy to improve symptoms of  fatigue related to 
inflammatory cytokines in obese patients with type 2 diabetes.
Keywords: Aerobic exercise, inflammatory cytokines, obesity, Type 2 diabetes, fatigue syndrome.
DOI: http://dx.doi.org/10.4314/ahs.v15i4.13
Cite as: Abd El-Kader SM, Al-Jiffri OH, Al-Shreef  FM. Aerobic exercises alleviate symptoms of  fatigue related to inflammatory cytokines 
in obese patients with type 2 diabetes.  Afri Health Sci. 2015;15(4):1142-8. http://dx.doi.org/10.4314/ahs.v15i4.13
 
Introduction
Patients with type 2 diabetes commonly experience fa-
tigue, which may be incapacitating and adversely affect 
self-care regimens1 which increases the risk of  other 
diabetic complication along with its adverse affection 
on diabetic patient quality of  life2,3. Most people with 
insulin-resistant type 2 diabetes are either overweight or 
obese4. Increased levels of  pro-inflammatory cytokines 
(as seen in obese individuals) may be significant factors 
in fatigue levels5. Fatigue is a perplexing problem for 
healthcare providers as fatigue is challenging to diag-
nose and treat. Fatigue in patients with type 2 diabetes 
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may be is associated with higher body mass index (BMI) 
and elevated cytokines6. 
 
Increased levels of  circulating inflammatory markers 
were found to be significantly more prominent in pa-
tients with type 2 diabetes7-10. Systemic inflammation in 
type 2 diabetes is believed to originate, at least partially, 
from the adipose tissue11-14.  The ability of  pro-inflam-
matory cytokines (e.g., interleukin – 6 (IL-6), tumor ne-
crosis factor-alpha (TNF)-α) to act on the brain and to 
induce behavioral symptoms, including fatigue, is well 
documented in both experimental and clinical studies15. 
However; aerobic exercises inhibit the production of  
inflammatory cytokines16.  
 
Data from observational studies suggest that low levels 
of  physical activity are associated with higher levels of  
fatigue in patients with type 2 diabetes16. The general 
benefits of  aerobic exercise training are well proved17 
and the cancer patients had less fatigue perception with 
increasing activities18. Much evidence supports the pos-
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itive effects of  regular physical activity on alleviating 
symptoms of  fatigue19,20.  
 
There is a considerable gap in the literature, however, 
about the treatment of  fatigue secondary to type 2 di-
abetes. Anti-inflammatory therapies may ameliorate fa-
tigue with type 2 diabetes. While there have been no 
clinical trials of  the effects of  an exercise intervention 
on fatigue symptoms in type 2 diabetes, results from 
exercise trials in both healthy and diverse disease pop-
ulations have shown that regular exercise may be an ef-
fective strategy for decreasing fatigue. Thus, our study 
was an attempt to assess the effects of  aerobic exercise 
upon fatigue symptoms associated with markers of  sys-





Eighty obese patients with type 2 diabetes were enrolled 
in this study; their age ranged from 40- 58 years and 
their BMI ranged from 31-36 kg/m2 and were selected 
from the Internal Medicine Department at King Abdul 
Aziz University hospital and other hospitals at Jeddah 
area. Exclusion criteria included major depressive disor-
der, endocrine disorders, smokers, chronic inflammato-
ry medical conditions, patients managed with psychiat-
ric medications. Participants were included two groups; 
group (A) received treadmill aerobic exercise training 
on treadmill and group (B) received no exercise train-
ing. All participants signed the informed consent. 
                                                                                                                                                      
Measurements
A. Anti-inflammatory cytokines assessment: Ve-
nous blood samples were drained from the antecubital 
vein after a 12-h fasting, the blood samples were cen-
trifuged at + 4 °C (1000 = g for 10 min). Interleukin-6 
levels were analyzed by “Immulite 2000” immunassay 
analyzer (Siemens Healthcare Diagnostics, Deerfield, 
USA). However, TNF-α and interleukin-8 (IL-8) levels 
were assessed by ELISA kits (ELX 50) in addition to 
ELISA microplate reader (ELX 808; BioTek Instru-
ments, USA). All analyses were done by Hitachi 7170 
Autoanalyser (Tokyo, Japan) and kits (Randox).
B. Fatigue Assessment: Fatigue was measured by 
completion of  the Multidimensional Fatigue Invento-
ry (MFI). The MFI was used to capture five distinct 
dimensions of  fatigue experienced ‘‘lately’’, including: 
general fatigue, physical fatigue, mental fatigue, and 
perceptions of  reduced motivation and reduced activ-
ity. In each of  the five subscales, scores range from 4 
to 20, with higher scores indicating greater fatigue. In 
order to minimize confounding factors imposed by di-
urnal variation, this questionnaire was completed on the 
morning of  the blood draw. Internal consistency for the 
MFI subscales was good (a = 0.82), suggesting the five 
domains adequately reflect a single construct21. 
 
All measurements of  TNF-α, Il-6, IL-8 and MFI were 
done at the beginning of  the study and repeated after 3 
months at the end of  the study.
 
Procedures
Following the previous evaluation , all patients were di-
vided randomly into the following groups:
1. Group (A) participated in a treadmill aerobic exercise 
which was conducted according to recommendations 
of  aerobic exercise application approved by the Ameri-
can College of  Sports Medicine22.Training program in-
cluded 5 minutes for warming up in the form of  range 
motion and stretching exercises, 10-30 minutes of  aer-
obic exercise training (60-70% of  maximum heart rate) 
and 10 minutes of  cooling down (on treadmill with low 
speed and without inclination). Participants had 3 ses-
sions /week for 3 months with close supervision of  a 
physical therapist.
2. Group (B) received no exercise training. 
 
Statistical analysis 
The mean values of  the investigated parameters ob-
tained before and after three months in both groups 
were compared using paired "t" test. Independent "t" 




Eighty obese patients with type 2 diabetes (44 men 
and 36 women) were enrolled in this study, there were 
no significant differences in age, body mass index, hip 
circumference, waist circumference, waist hip ratio, 
HbA1C, diabetes duration, systolic blood pressure and 
diastolic blood pressure between both groups (table 1). 
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There were 28.5 %, 26.2 %, 15.1%, 8 % and 25.4 % 
reduction in mean values of  TNF- α, IL-6, IL-8, BMI, 
MFI total score respectively in the training group (table 
2). 
Table 2:  Values of TNF- α, IL-6, IL-8, MFI total score and fatigue symptom dimensions  
in group (A) before and after treatment. 
 
  
Mean + SD t- 
value Significance Before treatment 
After 
treatment 
TNF-α (pg/mL) 6.15 ± 1.63* 4.37 ± 1.48 6.82     P <0.05 
IL-6 (pg/mL) 6.83 ± 2.15* 5.04 ± 1.92 5.87 P <0.05 
IL-8 (pg/mL) 14.17 ± 3.93* 12.03 ± 3.61 7.93 P <0.05 
BMI (kg/m2) 31.65 ± 5.53* 26.82 ± 4.88 7.58   P<0.05 
MFI total score 55.12 ±  12.94* 41.11± 13.72 6.54 P <0.05 
Fatigue symptom dimensions 
General fatigue 13.28± 2.85* 9.52± 3.61 5.43 P <0.05 
Physical fatigue 12.17 ± 3.16* 8.74 ± 2.92 6.76 P <0.05 
Reduced activity 11.33± 3.62* 8.15± 3.43 5.81 P <0.05 
Mental fatigue 9.11±3.72* 7.54± 3.24 6.74 P <0.05 
Reduced 
motivation 
9.23± 2.32* 7.16 ± 3.41 5.36 P <0.05 
 
TNF- α: tumor necrosis factor – alpha; IL-6: Interleukin-6; BMI: Body Mass Index; IL-8: Interleukin-8;  
MFI: Multidimensional Fatigue Inventory; (*) indicates a significant difference between the two groups, P < 0.05. 
While, there were 2.1% , 2.3 % , 0.42 % , 2.2 % and 2.1 
% increase in mean values of   TNF- α, IL-6, IL-8, BMI, 
MFI total score respectively in the control group. The 
mean values of  TNF- α, IL-6, IL-8, BMI, MFI total 
score were decreased significantly in the training group; 
however the results of  the control group were not sig-
nificant (table 3). 
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Table 1: Demographic and anthropometric characteristics of study participants. 
  
  Group (A) Group (B) Significance 
Sample size (N) 40 40      P >0.05 
Age (year) 43.62± 6.17 44.11 ±  5.89 P >0.05 
Gender (F/M) 19/20 17/22 P >0.05 
BMI (kg/m2) 31.65 ± 5.53 30.87 ± 5.76 P >0.05 
HC (cm) 123. 4813.17 121.7911.62 P >0.05 
WC (cm) 107.1110.56 106.5412.13 P >0.05 
WHR 0.950.07 0.920.07 P >0.05 
HbA1C (%)  8.941.85 8.571.47 P >0.05 
Diabetes duration (year)  11.422.16 10.831.97 P >0.05 
SBP(mmHg) 144.12 16.18 142.7614.34 P >0.05 
DBP (mmHg) 93.327.31 92.228.13 P >0.05 
 
BMI: Body Mass Index; HC: Hip circumference; WC: Waist circumference; WHR: Waist hip  
ratio HbA1C:  Glycosylated haemoglobin; SBP: Systolic blood pressure; DBP: Diastolic blood pressure.  
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Table 3: Values of TNF- α, IL-6, IL-8, MFI total score and fatigue symptom dimensions  
in group (B) before and at the end of the study. 
 
  
Mean + SD t- 
value Significance Before the study 
At the end of 
the study 
TNF-α (pg/mL) 5.98 ± 1.47 6.11 ± 1.42 0.87 P >0.05 
IL-6 (pg/mL) 6.42 ± 2.21 6.57 ± 2.18 0.63 P >0.05 
IL-8 (pg/mL) 14.31 ± 3.75 14.25 ± 3.70 0.41 P >0.05 
BMI (kg/m2) 31.14 ± 5.17 31.82 ± 5.38 0.95 P >0.05 
MFI total score 53.92 ±  11.82 55.03 ±  12.10 1.26 P >0.05 
Fatigue symptom dimensions 
General fatigue 13.17 ± 3.15 13.26 ± 3.13 0.61 P >0.05 
Physical fatigue 11.76 ± 2.96 12.14 ± 3.14 0.94 P >0.05 
Reduced activity 11.19 ± 3.21 11.35 ± 3.32 0.53 P >0.05 
Mental fatigue 8.93±3.52 9.16 ±3.43 0.96 P >0.05 
Reduced 
motivation 
8.87± 2.14 9.12 ± 2.25 0.84 P >0.05 
 
TNF- α: tumor necrosis factor – alpha; IL-6: Interleukin-6; BMI: Body Mass Index; IL-8: Interleukin-8;  
MFI: Multidimensional Fatigue Inventory. 
Moreover, there were significant differences between both groups at the end of  the study (table 4).
Table 4: Values of TNF- α, IL-6, IL-8, MFI total score and fatigue symptom dimensions 
in group (A) and group (B) at the end of the study. 
 
  Mean + SD t- value Significance Group (A) Group (B) 
TNF-α (pg/mL) 4.37 ± 1.48* 6.11 ± 1.42 7.15     P <0.05 
IL-6 (pg/mL) 5.04 ± 1.92* 6.57 ± 2.18 5.91 P <0.05 
IL-8 (pg/mL) 12.03 ± 3.61* 14.25 ± 3.70 7.71 P <0.05 
BMI (kg/m2) 26.82 ± 4.88* 31.42 ± 5.38 7.23   P<0.05 
MFI total score 41.11± 13.72* 55.03 ±  12.10 6.31 P <0.05 
Fatigue symptom dimensions 
General fatigue 9.52± 3.61* 13.26 ± 3.13 5.16 P <0.05 
Physical fatigue 8.74 ± 2.92* 12.14 ± 3.14 6.42 P <0.05 
Reduced 
activity 
8.15± 3.43* 11.35 ± 3.32 5.38 P <0.05 
Mental fatigue 7.54± 3.24* 9.16 ±3.43 6.53 P <0.05 
Reduced 
motivation 
7.16 ± 3.41* 9.12 ± 2.25 5.17 P <0.05 
TNF- α: tumor necrosis factor – alpha; IL-6: Interleukin-6; BMI: Body Mass Index; IL-8: Interleukin-8;  
MFI: Multidimensional Fatigue Inventory; (*) indicates a significant difference between the two groups, P < 0.05. 
Discussion
Diabetes mellitus is a major public health problem that 
affects approximately 6% of  the world's adult popula-
tion23. Fatigue represents a common complaint of  pa-
tients with diabetes as it can be reported in up to 60% 
of  patients24. This symptom not only impacts the pa-
tient’s quality of  life and compliance to treatment, but 
it is also associated with an increased risk of  diabetic 
complications25. Significant associations were found be-
tween fatigue symptom dimensions and circulating lev-
els of  inflammatory markers in obese patients with type 
2 diabetes, suggesting the involvement of  inflammatory 
processes in the development of  type 2 diabetes-related 
fatigue26. 
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To our knowledge, this is the first study addressing fa-
tigue symptoms associated with markers of  systemic 
inflammation parameters of  obese patients with type 2 
diabetes after 12 weeks of  concurrent training. We ob-
served reduction of  markers of  systemic inflammation 
and fatigue symptoms. The results of  our study agreed 
with several previous studies suggesting 12-weeks aer-
obic exercise training program promotes the modula-
tion of  systemic inflammation and fatigue symptoms 
of  obese patients with type 2 diabetes27-39.
 
Rosety-Rodriguez and colleagues conducted a 12-week 
arm cranking exercise program for spinal cord injury 
patients at a moderate work intensity of  50% to 65% of  
heart rate reserve for of  3 sessions per week . Their re-
sults proved that arm cranking exercise improved low-
grade systemic inflammation by decreasing plasma lev-
els of  inflammatory cytokines28. Trøseid and colleagues 
stated that 12 weeks exercise training program reduces 
plasma levels of  chemo-attractant protein-1 (MCP-1) 
and interleukin-8 (IL-8) in subjects with the metabolic 
syndrome29. Valentine and colleagues conducted a study 
on one hundred eighty-two community-dwelling older 
adults and their results proved that increasing physical 
activity levels had important implications for reducing 
their levels of  fatigue and markers of  systemic inflam-
mation30.   
 
Learmonth and colleagues conducted a pilot study to 
determine whether a 15-minute bout of  moderate-in-
tensity aerobic cycling exercise would affect symptoms 
(pain and fatigue) and function (Timed 25-Foot Walk 
test and Timed Up and Go test) in people with multiple 
sclerosis (MS) or chronic fatigue syndrome (CFS), their 
results suggest that people with MS or CFS may under-
take 15 minutes of  cycling as moderate aerobic exercise 
with no expected negative impact on pain, fatigue or 
function31. Sangelaji  and colleagues conducted a rand-
omized controlled clinical trial on 59 multiple sclerosis 
patients who received 10 weeks of  combination therapy 
including aerobic, strengthening, balancing and stretch-
ing exercises. Exercise had significant effect on improv-
ing balance, fatigue and quality of  life in multiple scle-
rosis patients32. Maniam and colleagues conducted an 
exercise program for hemodialysis patients,  three times 
a week for 12 weeks and concluded that  low-to-moder-
ate-intensity exercise is effective for improving fatigue, 
sleep disorders and the overall quality of  life among he-
modialysis patients33. 
Smith and colleagues conducted a study on sixty sub-
jects who completed a 12-week supervised exercise pro-
gram and concluded that supervised aerobic exercise 
training safely decreases fatigue, weight, BMI, subcu-
taneous fat and abdominal girth (central fat) in HIV-1- 
infected individuals34. Yang and colleagues proved that 
a mild to moderate-intensity aerobic exercise program 
for six weeks  reduces the fatigue of  Taiwanese women 
with breast cancer undergoing radiotherapy35. Durcan 
and colleagues conducted a 12-week exercise training 
program on forty rheumatoid arthritis patients. They 
concluded that exercise program resulted in significant 
improvement in sleep quality and fatigue36. Taso and 
colleagues proved that an eight week yoga exercise pro-
gram developed in this study effectively reduced fatigue 
in 60 patients with breast cancer but did not reduce de-
pression or anxiety37. 
The physiological mechanisms underlying these effects 
were not elucidated; however, both cancer and type 2 
diabetes are associated with higher levels of  inflamma-
tory cytokines and exercise may have anti-inflammatory 
properties38,39. 
 
The new finding in our study is that a program of  aer-
obic exercise training with an intensity 60-70% of  max-
imum heart rate for three months can improve symp-
toms of  fatigue related to inflammatory cytokines in 
obese patients with type 2 diabetes. 
    
Conclusion
The current study proved that treadmill walking exer-
cise training is an effective treatment policy to improve 
symptoms of  fatigue related to inflammatory cytokines 
in obese patients with type 2 diabetes.
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